Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Align Technology, Inc. ALGN

Healthcare  —  Medical Instruments & Supplies
146.78 1.15 0.79% as of 25 Sep
Market cap
$10.4B
P/E
25.5×
S&P 500 Member Revenue Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Align Technology, Inc. (ALGN) EV/EBITDA

As of 25 September 2026, Align Technology, Inc. (ALGN) trades at a EV/EBITDA of 11.7×. Over the past ten years it has ranged from 10.8× (September 2025) to 100× (December 2020); the current reading is higher than 1% of that period. That is below the Medical Instruments & Supplies industry median of 16.1× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 13.1× (32.50%)
FY2024 19.4× (22.32%)
FY2023 24.9× 22.75%
FY2022 20.3× (56.54%)
FY2021 46.7× (45.40%)
FY2020 85.6× 149.70%
FY2019 34.3× 11.41%
FY2018 30.8× (30.29%)
FY2017 44.1× 69.54%
FY2016 26.0× 13.44%

Quarterly

Period EV/EBITDA Change
Jun 2026 13.7× (0.89%)
Mar 2026 13.8× 5.50%
Dec 2025 13.1× 14.81%
Sep 2025 11.4× (32.97%)
42 more quarters

Against its own ten years

Low 10.8× High 100×
Ten-year median 27.4×
Current reading's percentile 1

EV/EBITDA against peers

Company EV/EBITDA
SOLV Solventum Corporation compare 7.9×
ATR AptarGroup, Inc. compare 11.5×
ALGN Align Technology, Inc. 11.7×
BAX Baxter International Inc. compare 13.3×
COO The Cooper Companies, Inc. compare 14.1×
BLCO Bausch + Lomb Corporation compare 14.4×
STVN Stevanato Group S.p.A. compare 18.1×
RGEN Repligen Corporation compare 65.3×
AVTR Avantor, Inc. compare 110×
Medical Instruments & Supplies industry median 16.1×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ALGN